Do DCs influence the antiviral effect of interferon/ribavirin by changing their profile during the therapy?
Takahashi
Hiroki
H
Zeniya
Mikio
M
D000998:Antiviral Agents / Q000494:pharmacology*; D003713:Dendritic Cells / Q000276:immunology*; D016174:Hepacivirus / Q000472:pathogenicity; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D012254:Ribavirin / Q000494:pharmacology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin